Careteq Ltd. · ASX:CTQ

Careteq — FY2022 Earnings Presentation

17 slides from Careteq's earnings presentation, Aug 8, 2022

  1. Slide 1: Full Year Presentation August 2022

    Full Year Presentation August 2022 Constant Care, everywhere

  2. Slide 2: Disclaimer and Important Notices

    Disclaimer and Important Notices This presentation has been prepared by Careteq Limited ACN 612 267 857 (Company). It contains general implied, as to the accuracy, completeness, likelihood of achievement or reasonableness of any Forward background information only which is current at the date of thi

  3. Slide 3: Company Overview

    Company Overview AN AUSTRALIAN COMPANY WITH A FOCUS ON HEALTH AND AGED CARE For personal use only CARETEQ has developed a comprehensive SaaS-based solution Market Matrix* and is an early mover in the rapidly growing Assistive Living Technology sector. CARETEQ (ASX: CTQ) listed on the Australian Secu

  4. Slide 4: FY2022 Financial Performance

    FY2022 Financial Performance *

  5. Slide 5: Laying the Groundwork in FY2022

    Laying the Groundwork in FY2022 POSITIONING FOR A STEP-CHANGE For personal use only FY23 Inflection Point Careteq Listed on the ASX in Jan 2022 • Rapid expansion in sales pipeline with >60 active opportunities • One-third of these opportunities in the US FY22 Foundation Year with balance in Australi

  6. Slide 6: Business Model

    Business Model DEFENSIVE AND GROWING INCOME FROM THREE PRIMARY REVENUE STREAMS For personal use only Hardware Sales SaaS Subscriptions Contractual Revenue • Sales of devices for safety, falls • Users/carers can control and manage • Medication Management (MM) reviews detection, activity monitoring an

  7. Slide 7: Expanding Pipeline of Opportunities

    Expanding Pipeline of Opportunities REACHING FOR FY2023 INFLECTION POINT For personal use only Active Opportunities by Industry (US & Australia) Sales Pipeline by Geography Careteq's Sales Pipeline (US & Australia) 5% Leads 60% 10% Facilities Demos 18% 1/3rd 44% 6 Months plus 19% Retail/Distrib utio

  8. Slide 8: Building on the Momentum: FY2022 Results Highlights

    Building on the Momentum § Geared for Growth with rapidly growing sales pipeline and strong balance FY2022 RESULTS HIGHLIGHTS sheet § Five-fold Increase in Sales Pipeline For personal use only in just six months and currently managing >60 active sales FY22 FY21 opportunities in US & Australia SaaS S

  9. Slide 9: More Room for Sales Pipeline to Expand

    More Room for Sales Pipeline to Expand RIGHT PLACE RIGHT TIME AUS/NZ For personal use only • Careteq’s Assistive Living $22.7b $995m Technology platform and solutions TAM SAM are gaining momentum in Australia and the US TAM: Total Addressable Market • Increasing need to improve the GLOBAL standard o

  10. Slide 10: Subscription & Hardware Sales

    Subscription & Hardware Sales § Enables big data capture and enhanced granularity CLOUD-BASED PLATFORM + SMART SENSORS § Constant real-time stream of multiple data variables delivering broad detail on activities and occurrences For personal use only Unique Radar § Can be accessed through various dev

  11. Slide 11: Solid Performance from Ward MM

    Solid Performance from Ward MM FURTHER GROWTH IN FY2022 For personal use only Market Leading Medication Management Business – Ward MM § Largest medication management database in Australia with 350+ residential aged care (RAC) facilities and 34,000+ beds § Acquired by Careteq in August 2021 § 3-year

  12. Slide 12: New Markets and Outlook

    New Markets and Outlook

  13. Slide 13: Significant New Market: Lone Worker

    Significant New Market NEW SALES TO LONE WORKER MARKET For personal use only § Initial sales of TEQ-Secure Working separately from others safety pendants via (e.g., factories, warehouses, petrol stations, Working away from a fixed base kiosks) (e.g., construction, plant installation, existing channe

  14. Slide 14: Hospital-in-the-home Market

    Hospital-in-the-home Market For personal use only NEW OFFERING § Hospital in the Home is growing rapidly in Australia and presents a new significant opportunity for Careteq § Careteq is in discussions with prominent healthcare groups within Australia § Logical extension of Careteq’s solution suite t

  15. Slide 15: Positive Outlook for FY2023

    Positive Outlook FOR FY2023 For personal use only Growth Growth Options FY23 inflection year with Multiple near-term growth potential step-change in options (including new growth markets) to build scale in Australia and internationally Momentum Prospective Customers Growth momentum High levels of in

  16. Slide 16: Deep Experience in Health Care

    Deep Experience in Health Care BOARD DIRECTORS For personal use only Mark Simari Alex Boyd Brett Cheong Stephen Munday Executive Chairman Executive Director / COO Non-Executive Director Non-Executive Director Over 14 years’ Board experience Over two decades of experience Over 40 years of background

  17. Slide 17: Thank You

    THANK YOU For personal use only MARK SIMARI Executive Chairman mark.simari@careteq.com.au BRENDON LAU Investor Relations brendon@vantagepointpartners.com.au CORPORATE ADDRESS CARETEQ Level 10 99 Queen Street Melbourne 3000 FULL YEAR REPORT | 2022 17

Careteq — FY2022 Earnings Presentation on 6ix